NCT03737734 2026-04-06
Alpha Radiation Emitters Device for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia (DaRT)
Alpha Tau Medical LTD.
Phase NA Active not recruiting
Clinical Trials
37 trialsNCT03886181 2025-12-08
Alpha Radiation Emitters Device for the Treatment of Cutaneous, Mucosal and Superficial Soft Tissue Neoplasia (DaRT)
Alpha Tau Medical LTD.
Phase NA Terminated
NCT03889899 2025-12-02
Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia.
Alpha Tau Medical LTD.
Phase NA Recruiting
NCT04540588 2025-12-02
Retreatment With Intratumoral Diffusing Alpha Radiation Emitters
Alpha Tau Medical LTD.
Phase NA Completed
NCT03157167 2025-03-05
An Evaluation of Tc 99m Tilmanocept by Intravenous (IV) and Subcutaneous (SC) Injection in Kaposi Sarcoma (KS)
Navidea Biopharmaceuticals
Phase 1 Completed
NCT04534127 2025-02-07
Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia
Alpha Tau Medical LTD.
Phase NA Recruiting
NCT02029430 2024-06-11
A Study to Investigate ALDOXORUBICIN in HIV-infected Subjects With Kaposi's Sarcoma
ImmunityBio, Inc.
Phase 2 Completed
NCT03993106 2024-05-02
A Study of sEphB4-HSA in Kaposi Sarcoma
Vasgene Therapeutics, Inc
Phase 2 Recruiting
NCT05329792 2023-10-06
IntriNSiC
Philogen S.p.A.
Phase 2 Unknown
NCT02229981 2017-12-07
ABC-102
RedHill Biopharma Limited
Phase 1/2 Withdrawn
NCT02201420 2016-09-27
Evaluation of Tc 99m Tilmanocept Localization in Primary Cutaneous Kaposi's Sarcoma and Lymphatic Drainage by SPECT/CT
Navidea Biopharmaceuticals
Phase 2 Completed
NCT00003720 2012-08-23
SU5416 in Treating Patients With AIDS-Related Kaposi's Sarcoma
Pfizer
Phase 1 Completed
NCT00051597 2011-10-12
A Safety/Efficacy Study of SGN-30 (Antibody) in Patients With Refractory or Recurrent CD30+ Hematologic Malignancies
Seagen Inc.
Phase 1/2 Completed
NCT00002366 2009-02-20
The Safety and Effectiveness of Ritonavir in the Treatment of HIV-Related Kaposi's Sarcoma
Abbott
Phase 2 Completed
NCT00002093 2005-06-24
A Randomized Phase III Clinical Trial of Daunoxome Versus Combination Chemotherapy With Adriamycin/Bleomycin/Vincristine (ABV) in the Treatment of HIV-Associated Kaposi's Sarcoma.
NIH AIDS Clinical Trials Information Service
Phase 3 Completed
NCT00002105 2005-06-24
Randomized, Comparative Trial of DOX-SL (Stealth Liposomal Doxorubicin Hydrochloride) Versus Bleomycin and Vincristine in the Treatment of AIDS-Related Kaposi's Sarcoma
NIH AIDS Clinical Trials Information Service
Phase 3 Completed
NCT00002131 2005-06-24
A Pilot Study of OPC-8212 (Vesnarinone) in Persons With AIDS-Related Kaposi's Sarcoma
NIH AIDS Clinical Trials Information Service
Phase 2 Completed
NCT00002136 2005-06-24
A Phase I Trial of Tecogalan Sodium (DS-4152) Administered as an Infusion Every 21 Days
NIH AIDS Clinical Trials Information Service
Phase 1 Completed
NCT00002137 2005-06-24
A Phase I Trial of Tecogalan Sodium ( DS-4152 ) Administered as an Infusion Weekly x 4
NIH AIDS Clinical Trials Information Service
Phase 1 Completed
NCT00002138 2005-06-24
A Phase I Trial of Tecogalan Sodium ( DS-4152 ) Administered as an Infusion Twice Weekly for 21 Days.
NIH AIDS Clinical Trials Information Service
Phase 1 Completed
NCT00002147 2005-06-24
Use of Stealth Liposomal Doxorubicin HCl ( DOX-SL ) in the Treatment of Moderate to Severe AIDS-Related Kaposi's Sarcoma.
NIH AIDS Clinical Trials Information Service
Phase 3 Completed
NCT00002153 2005-06-24
Topical Use of 4,4'-Dihydroxybenzophenone-2,4-Dinitrophenylhydrazone (A-007) in the Treatment of Advanced Malignancies Including Kaposi's Sarcoma and Lymphoproliferative Disorders
NIH AIDS Clinical Trials Information Service
Phase 1 Completed
NCT00002167 2005-06-24
Photodynamic Therapy Clinical Trial For Cutaneous AIDS-Related Kaposi's Sarcoma Study Summary.
NIH AIDS Clinical Trials Information Service
Phase 2 Completed
NCT00002185 2005-06-24
A Pilot, Open-Label, Phase II, Randomized Study to Determine the Effects of Viracept on the Outcome of Cutaneous and Mucosal KS in AIDS Patients With CD4 <= 500 Cells/mm3
NIH AIDS Clinical Trials Information Service
Phase 2 Completed
NCT00002188 2005-06-24
A Study of ALRT1057 in Patients With AIDS-Related Kaposi's Sarcoma
NIH AIDS Clinical Trials Information Service
Phase 2 Completed
NCT00002189 2005-06-24
Paclitaxel in Advanced Refractory Kaposi's Sarcoma (AIDS-KS): A Phase II Trial of Paclitaxel From Baker Norton Pharmaceuticals
NIH AIDS Clinical Trials Information Service
Phase 2 Completed
NCT00002212 2005-06-24
A Study of Targretin Capsules in Patients With AIDS-Related Kaposi's Sarcoma
NIH AIDS Clinical Trials Information Service
Phase 2 Completed
NCT00002226 2005-06-24
Safety and Effectiveness of Giving SU5416 to HIV-Infected Patients With AIDS-Related Kaposi's Sarcoma
NIH AIDS Clinical Trials Information Service
Phase NA Completed
NCT00002259 2005-06-24
Phase II Study of Intravenous Novantrone(R) in the Treatment of AIDS Related Kaposi's Sarcoma
NIH AIDS Clinical Trials Information Service
Phase 2 Completed
NCT00002262 2005-06-24
A Phase I/II Study of Intralesional Recombinant Tumor Necrosis Factor in Patients With AIDS-Related Cutaneous Kaposi's Sarcoma
NIH AIDS Clinical Trials Information Service
Phase 1 Completed
NCT00002314 2005-06-24
A Study of Ro 24-7429 in Patients With HIV-Related Kaposi's Sarcoma
NIH AIDS Clinical Trials Information Service
Phase 2 Completed
NCT00002318 2005-06-24
A Comparison of DOX-SL Versus Adriamycin Plus Bleomycin Plus Vincristine in the Treatment of Severe AIDS-Related Kaposi's Sarcoma
NIH AIDS Clinical Trials Information Service
Phase 3 Unknown
NCT00002319 2005-06-24
A Study of DOX-SL in the Treatment of AIDS-Related Kaposi's Sarcoma
NIH AIDS Clinical Trials Information Service
Phase 3 Completed
NCT00002342 2005-06-24
A Study of Tecogalan Sodium
NIH AIDS Clinical Trials Information Service
Phase 1 Completed
NCT00002439 2005-06-24
A Study of ALRT 1057 Topical Gel in Patients With AIDS-Related Kaposi's Sarcoma
NIH AIDS Clinical Trials Information Service
Phase NA Completed
NCT00002445 2005-06-24
Safety and Effectiveness of an Experimental Drug, IM862, in Treating Kaposi's Sarcoma in AIDS Patients
NIH AIDS Clinical Trials Information Service
Phase 3 Completed
NCT00005931 2005-06-24
SU5416 in Patients With AIDS-Related Kaposi's Sarcoma Who Have Not Responded to Treatment
NIH AIDS Clinical Trials Information Service
Phase 2 Completed